Skip to content

Attention and Visual Perception in Schizophrenia: A Functional Magnetic Resonance Imaging (fMRI) Study

Attention and Grouping of Visual Information: What is Disturbed in Patients With Schizophrenia?

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00350935
Enrollment
52
Registered
2006-07-11
Start date
2006-09-30
Completion date
2009-04-30
Last updated
2010-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Keywords

fMRI, Visual perception, Attention

Brief summary

The main objective of the study is to contribute to a better understanding of the physiopathology of schizophrenia, by studying causal relationships between cognitive deficits and the neurobiological basis for these deficits. Processing visual information involves both automatic grouping processes and control processes. Automatic grouping processes allow the building of a global configuration from local contour information. It is necessary in order to recognize objects. Control processes allow tending to and prioritizing information parts. The paradigm the investigators use allows to dissociate these processes, and is used in order to characterize the impairments observed in patients with schizophrenia. It is adapted to fMRI in order to explore the neurobiological basis of the deficits. The investigators will examine whether functional disconnectivity between activated areas subtend the impairments observed in patients.

Interventions

PROCEDUREfMRI

One 30 minute session

Sponsors

Institut National de la Santé Et de la Recherche Médicale, France
CollaboratorOTHER_GOV
Centre National de la Recherche Scientifique, France
CollaboratorOTHER
Région Alsace
CollaboratorUNKNOWN
Faculté de Médecine de Strasbourg
CollaboratorUNKNOWN
University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients with schizophrenia (DSM-IV criteria) * Healthy controls matched with patients on age, sex and education level * Ages 18 to 50 * Signed informed consent * Right-handed

Exclusion criteria

* No severe somatic illness * No invalidating sensory disease * No drug abuse, as defined by DSM-IV criteria * No general anaesthesia in the past 3 months * No intake of drugs affecting the CNS, except for patients

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026